nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—GSR—saliva-secreting gland—thyroid cancer	0.00519	0.285	CbGeAlD
Carmustine—GSR—trachea—thyroid cancer	0.00401	0.22	CbGeAlD
Carmustine—Hypokinesia—Epirubicin—thyroid cancer	0.00346	0.00352	CcSEcCtD
Carmustine—Stomatitis—Sorafenib—thyroid cancer	0.00345	0.00351	CcSEcCtD
Carmustine—Myasthenia—Doxorubicin—thyroid cancer	0.00344	0.0035	CcSEcCtD
Carmustine—Oral candidiasis—Doxorubicin—thyroid cancer	0.0034	0.00347	CcSEcCtD
Carmustine—Burning sensation—Epirubicin—thyroid cancer	0.00336	0.00342	CcSEcCtD
Carmustine—Oedema—Vandetanib—thyroid cancer	0.00334	0.0034	CcSEcCtD
Carmustine—Infection—Vandetanib—thyroid cancer	0.00332	0.00338	CcSEcCtD
Carmustine—Thrombosis—Epirubicin—thyroid cancer	0.0033	0.00336	CcSEcCtD
Carmustine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00327	0.00333	CcSEcCtD
Carmustine—Cyst—Doxorubicin—thyroid cancer	0.00323	0.00329	CcSEcCtD
Carmustine—Hypokinesia—Doxorubicin—thyroid cancer	0.0032	0.00326	CcSEcCtD
Carmustine—Haemoglobin—Sorafenib—thyroid cancer	0.00319	0.00325	CcSEcCtD
Carmustine—Haemorrhage—Sorafenib—thyroid cancer	0.00317	0.00323	CcSEcCtD
Carmustine—GSR—thyroid gland—thyroid cancer	0.00317	0.174	CbGeAlD
Carmustine—Connective tissue disorder—Sorafenib—thyroid cancer	0.00312	0.00318	CcSEcCtD
Carmustine—Burning sensation—Doxorubicin—thyroid cancer	0.00311	0.00317	CcSEcCtD
Carmustine—Scotoma—Epirubicin—thyroid cancer	0.00308	0.00313	CcSEcCtD
Carmustine—Thrombosis—Doxorubicin—thyroid cancer	0.00305	0.00311	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00305	0.0031	CcSEcCtD
Carmustine—Insomnia—Vandetanib—thyroid cancer	0.00302	0.00308	CcSEcCtD
Carmustine—Paraesthesia—Vandetanib—thyroid cancer	0.003	0.00306	CcSEcCtD
Carmustine—Dyspnoea—Vandetanib—thyroid cancer	0.00298	0.00304	CcSEcCtD
Carmustine—Necrosis—Epirubicin—thyroid cancer	0.00298	0.00303	CcSEcCtD
Carmustine—Abscess—Epirubicin—thyroid cancer	0.00295	0.00301	CcSEcCtD
Carmustine—Flushing—Sorafenib—thyroid cancer	0.00295	0.003	CcSEcCtD
Carmustine—Decreased appetite—Vandetanib—thyroid cancer	0.00291	0.00296	CcSEcCtD
Carmustine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00289	0.00294	CcSEcCtD
Carmustine—Injection site pain—Epirubicin—thyroid cancer	0.00286	0.00291	CcSEcCtD
Carmustine—Constipation—Vandetanib—thyroid cancer	0.00286	0.00291	CcSEcCtD
Carmustine—Pain—Vandetanib—thyroid cancer	0.00286	0.00291	CcSEcCtD
Carmustine—Scotoma—Doxorubicin—thyroid cancer	0.00285	0.0029	CcSEcCtD
Carmustine—Arrhythmia—Sorafenib—thyroid cancer	0.00284	0.00289	CcSEcCtD
Carmustine—GSR—head—thyroid cancer	0.00281	0.154	CbGeAlD
Carmustine—Alopecia—Sorafenib—thyroid cancer	0.0028	0.00286	CcSEcCtD
Carmustine—Mental disorder—Sorafenib—thyroid cancer	0.00278	0.00283	CcSEcCtD
Carmustine—Erythema—Sorafenib—thyroid cancer	0.00276	0.00281	CcSEcCtD
Carmustine—Malnutrition—Sorafenib—thyroid cancer	0.00276	0.00281	CcSEcCtD
Carmustine—Necrosis—Doxorubicin—thyroid cancer	0.00275	0.0028	CcSEcCtD
Carmustine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00273	0.00278	CcSEcCtD
Carmustine—Abscess—Doxorubicin—thyroid cancer	0.00273	0.00278	CcSEcCtD
Carmustine—Extravasation—Epirubicin—thyroid cancer	0.00268	0.00273	CcSEcCtD
Carmustine—Injection site pain—Doxorubicin—thyroid cancer	0.00265	0.0027	CcSEcCtD
Carmustine—Abdominal pain—Vandetanib—thyroid cancer	0.00264	0.00269	CcSEcCtD
Carmustine—Body temperature increased—Vandetanib—thyroid cancer	0.00264	0.00269	CcSEcCtD
Carmustine—Anaemia—Sorafenib—thyroid cancer	0.00255	0.0026	CcSEcCtD
Carmustine—Thinking abnormal—Epirubicin—thyroid cancer	0.00255	0.0026	CcSEcCtD
Carmustine—Extravasation—Doxorubicin—thyroid cancer	0.00248	0.00252	CcSEcCtD
Carmustine—Leukopenia—Sorafenib—thyroid cancer	0.00247	0.00252	CcSEcCtD
Carmustine—Asthenia—Vandetanib—thyroid cancer	0.0024	0.00244	CcSEcCtD
Carmustine—Gait disturbance—Epirubicin—thyroid cancer	0.00239	0.00244	CcSEcCtD
Carmustine—Hypertension—Sorafenib—thyroid cancer	0.00239	0.00243	CcSEcCtD
Carmustine—Coordination abnormal—Epirubicin—thyroid cancer	0.00238	0.00242	CcSEcCtD
Carmustine—Neck pain—Epirubicin—thyroid cancer	0.00236	0.00241	CcSEcCtD
Carmustine—Thinking abnormal—Doxorubicin—thyroid cancer	0.00236	0.0024	CcSEcCtD
Carmustine—Myalgia—Sorafenib—thyroid cancer	0.00235	0.0024	CcSEcCtD
Carmustine—Pulmonary embolism—Epirubicin—thyroid cancer	0.00234	0.00238	CcSEcCtD
Carmustine—Injection site reaction—Epirubicin—thyroid cancer	0.00232	0.00237	CcSEcCtD
Carmustine—Diarrhoea—Vandetanib—thyroid cancer	0.00229	0.00233	CcSEcCtD
Carmustine—Infection—Sorafenib—thyroid cancer	0.00224	0.00228	CcSEcCtD
Carmustine—Skin exfoliation—Epirubicin—thyroid cancer	0.00223	0.00227	CcSEcCtD
Carmustine—Candida infection—Epirubicin—thyroid cancer	0.00223	0.00227	CcSEcCtD
Carmustine—Gait disturbance—Doxorubicin—thyroid cancer	0.00221	0.00226	CcSEcCtD
Carmustine—Dizziness—Vandetanib—thyroid cancer	0.00221	0.00225	CcSEcCtD
Carmustine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00221	0.00225	CcSEcCtD
Carmustine—Coordination abnormal—Doxorubicin—thyroid cancer	0.0022	0.00224	CcSEcCtD
Carmustine—Neuropathy—Epirubicin—thyroid cancer	0.00219	0.00223	CcSEcCtD
Carmustine—Neck pain—Doxorubicin—thyroid cancer	0.00219	0.00223	CcSEcCtD
Carmustine—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00216	0.0022	CcSEcCtD
Carmustine—Anorexia—Sorafenib—thyroid cancer	0.00215	0.00219	CcSEcCtD
Carmustine—Injection site reaction—Doxorubicin—thyroid cancer	0.00215	0.00219	CcSEcCtD
Carmustine—Coma—Epirubicin—thyroid cancer	0.00213	0.00217	CcSEcCtD
Carmustine—Vomiting—Vandetanib—thyroid cancer	0.00213	0.00216	CcSEcCtD
Carmustine—Neoplasm—Epirubicin—thyroid cancer	0.00211	0.00215	CcSEcCtD
Carmustine—Rash—Vandetanib—thyroid cancer	0.00211	0.00215	CcSEcCtD
Carmustine—Dermatitis—Vandetanib—thyroid cancer	0.00211	0.00214	CcSEcCtD
Carmustine—Headache—Vandetanib—thyroid cancer	0.00209	0.00213	CcSEcCtD
Carmustine—Candida infection—Doxorubicin—thyroid cancer	0.00206	0.0021	CcSEcCtD
Carmustine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00206	0.0021	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00205	0.00209	CcSEcCtD
Carmustine—Abnormal vision—Epirubicin—thyroid cancer	0.00204	0.00207	CcSEcCtD
Carmustine—Neuropathy—Doxorubicin—thyroid cancer	0.00203	0.00207	CcSEcCtD
Carmustine—Sepsis—Epirubicin—thyroid cancer	0.00203	0.00206	CcSEcCtD
Carmustine—Mental disability—Epirubicin—thyroid cancer	0.00203	0.00206	CcSEcCtD
Carmustine—Dyspnoea—Sorafenib—thyroid cancer	0.00201	0.00205	CcSEcCtD
Carmustine—Nausea—Vandetanib—thyroid cancer	0.00199	0.00202	CcSEcCtD
Carmustine—Coma—Doxorubicin—thyroid cancer	0.00197	0.00201	CcSEcCtD
Carmustine—GSR—lymph node—thyroid cancer	0.00197	0.108	CbGeAlD
Carmustine—Phlebitis—Epirubicin—thyroid cancer	0.00197	0.002	CcSEcCtD
Carmustine—Decreased appetite—Sorafenib—thyroid cancer	0.00196	0.002	CcSEcCtD
Carmustine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00196	0.002	CcSEcCtD
Carmustine—Neoplasm—Doxorubicin—thyroid cancer	0.00195	0.00199	CcSEcCtD
Carmustine—Diabetes mellitus—Epirubicin—thyroid cancer	0.00195	0.00199	CcSEcCtD
Carmustine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00195	0.00198	CcSEcCtD
Carmustine—Constipation—Sorafenib—thyroid cancer	0.00193	0.00196	CcSEcCtD
Carmustine—Pain—Sorafenib—thyroid cancer	0.00193	0.00196	CcSEcCtD
Carmustine—Abnormal vision—Doxorubicin—thyroid cancer	0.00188	0.00192	CcSEcCtD
Carmustine—Eye pain—Epirubicin—thyroid cancer	0.00188	0.00191	CcSEcCtD
Carmustine—Sepsis—Doxorubicin—thyroid cancer	0.00188	0.00191	CcSEcCtD
Carmustine—Mental disability—Doxorubicin—thyroid cancer	0.00188	0.00191	CcSEcCtD
Carmustine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00184	0.00188	CcSEcCtD
Carmustine—Phlebitis—Doxorubicin—thyroid cancer	0.00182	0.00185	CcSEcCtD
Carmustine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00181	0.00185	CcSEcCtD
Carmustine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.0018	0.00184	CcSEcCtD
Carmustine—Abdominal pain—Sorafenib—thyroid cancer	0.00178	0.00182	CcSEcCtD
Carmustine—Body temperature increased—Sorafenib—thyroid cancer	0.00178	0.00182	CcSEcCtD
Carmustine—Eye pain—Doxorubicin—thyroid cancer	0.00174	0.00177	CcSEcCtD
Carmustine—Hyponatraemia—Epirubicin—thyroid cancer	0.0017	0.00173	CcSEcCtD
Carmustine—Diplopia—Epirubicin—thyroid cancer	0.0017	0.00173	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.0017	0.00173	CcSEcCtD
Carmustine—Hypersensitivity—Sorafenib—thyroid cancer	0.00166	0.00169	CcSEcCtD
Carmustine—Face oedema—Epirubicin—thyroid cancer	0.00164	0.00167	CcSEcCtD
Carmustine—Asthenia—Sorafenib—thyroid cancer	0.00162	0.00165	CcSEcCtD
Carmustine—Ataxia—Epirubicin—thyroid cancer	0.00159	0.00162	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—thyroid cancer	0.00158	0.0016	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—thyroid cancer	0.00157	0.0016	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00157	0.0016	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—thyroid cancer	0.00157	0.00159	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—thyroid cancer	0.00154	0.00157	CcSEcCtD
Carmustine—Diarrhoea—Sorafenib—thyroid cancer	0.00154	0.00157	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—thyroid cancer	0.00151	0.00154	CcSEcCtD
Carmustine—Muscular weakness—Epirubicin—thyroid cancer	0.0015	0.00152	CcSEcCtD
Carmustine—Dizziness—Sorafenib—thyroid cancer	0.00149	0.00152	CcSEcCtD
Carmustine—Ataxia—Doxorubicin—thyroid cancer	0.00148	0.0015	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—thyroid cancer	0.00147	0.00149	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00145	0.00148	CcSEcCtD
Carmustine—Vomiting—Sorafenib—thyroid cancer	0.00143	0.00146	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00143	0.00145	CcSEcCtD
Carmustine—Rash—Sorafenib—thyroid cancer	0.00142	0.00145	CcSEcCtD
Carmustine—Dermatitis—Sorafenib—thyroid cancer	0.00142	0.00145	CcSEcCtD
Carmustine—Headache—Sorafenib—thyroid cancer	0.00141	0.00144	CcSEcCtD
Carmustine—Pancytopenia—Epirubicin—thyroid cancer	0.00139	0.00142	CcSEcCtD
Carmustine—Muscular weakness—Doxorubicin—thyroid cancer	0.00138	0.00141	CcSEcCtD
Carmustine—Neutropenia—Epirubicin—thyroid cancer	0.00137	0.0014	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—thyroid cancer	0.00136	0.00138	CcSEcCtD
Carmustine—Nausea—Sorafenib—thyroid cancer	0.00134	0.00136	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00132	0.00135	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—thyroid cancer	0.00131	0.00134	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—thyroid cancer	0.00129	0.00131	CcSEcCtD
Carmustine—Renal failure—Epirubicin—thyroid cancer	0.00128	0.00131	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00128	0.0013	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—thyroid cancer	0.00127	0.0013	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—thyroid cancer	0.00127	0.00129	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—thyroid cancer	0.00127	0.00129	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00122	0.00125	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—thyroid cancer	0.00122	0.00124	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—thyroid cancer	0.00119	0.00121	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00119	0.00121	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—thyroid cancer	0.00118	0.0012	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—thyroid cancer	0.00118	0.0012	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00118	0.0012	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Carmustine—Oedema peripheral—Epirubicin—thyroid cancer	0.00116	0.00118	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00115	0.00117	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—thyroid cancer	0.00113	0.00115	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—thyroid cancer	0.0011	0.00112	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—thyroid cancer	0.00109	0.00111	CcSEcCtD
Carmustine—Flushing—Epirubicin—thyroid cancer	0.00109	0.00111	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—thyroid cancer	0.00109	0.00111	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00108	0.0011	CcSEcCtD
Carmustine—CYP1A2—thyroid gland—thyroid cancer	0.00108	0.0591	CbGeAlD
Carmustine—Oedema peripheral—Doxorubicin—thyroid cancer	0.00107	0.00109	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00107	0.00109	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Carmustine—Alopecia—Epirubicin—thyroid cancer	0.00104	0.00106	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—thyroid cancer	0.00103	0.00105	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—thyroid cancer	0.00102	0.00104	CcSEcCtD
Carmustine—Erythema—Epirubicin—thyroid cancer	0.00102	0.00104	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—thyroid cancer	0.00101	0.00103	CcSEcCtD
Carmustine—Flushing—Doxorubicin—thyroid cancer	0.00101	0.00103	CcSEcCtD
Carmustine—Back pain—Epirubicin—thyroid cancer	0.000988	0.00101	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—thyroid cancer	0.00097	0.000988	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—thyroid cancer	0.000962	0.00098	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—thyroid cancer	0.000959	0.000977	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—thyroid cancer	0.000951	0.000968	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—thyroid cancer	0.000945	0.000962	CcSEcCtD
Carmustine—Erythema—Doxorubicin—thyroid cancer	0.000945	0.000962	CcSEcCtD
Carmustine—Anaemia—Epirubicin—thyroid cancer	0.000944	0.000961	CcSEcCtD
Carmustine—Agitation—Epirubicin—thyroid cancer	0.000938	0.000956	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—thyroid cancer	0.000914	0.000931	CcSEcCtD
Carmustine—Back pain—Doxorubicin—thyroid cancer	0.000914	0.000931	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—thyroid cancer	0.00089	0.000907	CcSEcCtD
Carmustine—Convulsion—Epirubicin—thyroid cancer	0.000885	0.000901	CcSEcCtD
Carmustine—Hypertension—Epirubicin—thyroid cancer	0.000882	0.000898	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—thyroid cancer	0.000873	0.000889	CcSEcCtD
Carmustine—Chest pain—Epirubicin—thyroid cancer	0.000869	0.000885	CcSEcCtD
Carmustine—Myalgia—Epirubicin—thyroid cancer	0.000869	0.000885	CcSEcCtD
Carmustine—Agitation—Doxorubicin—thyroid cancer	0.000868	0.000884	CcSEcCtD
Carmustine—Anxiety—Epirubicin—thyroid cancer	0.000866	0.000882	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—thyroid cancer	0.000846	0.000861	CcSEcCtD
Carmustine—Confusional state—Epirubicin—thyroid cancer	0.00084	0.000856	CcSEcCtD
Carmustine—Oedema—Epirubicin—thyroid cancer	0.000833	0.000849	CcSEcCtD
Carmustine—Infection—Epirubicin—thyroid cancer	0.000828	0.000843	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—thyroid cancer	0.000819	0.000834	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000816	0.000831	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—thyroid cancer	0.000816	0.000831	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—thyroid cancer	0.000813	0.000828	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—thyroid cancer	0.000804	0.000819	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—thyroid cancer	0.000804	0.000819	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—thyroid cancer	0.000802	0.000816	CcSEcCtD
Carmustine—Anorexia—Epirubicin—thyroid cancer	0.000794	0.000809	CcSEcCtD
Carmustine—Hypotension—Epirubicin—thyroid cancer	0.000779	0.000793	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—thyroid cancer	0.000777	0.000792	CcSEcCtD
Carmustine—Oedema—Doxorubicin—thyroid cancer	0.000771	0.000785	CcSEcCtD
Carmustine—Infection—Doxorubicin—thyroid cancer	0.000766	0.00078	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000759	0.000773	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000755	0.000769	CcSEcCtD
Carmustine—Insomnia—Epirubicin—thyroid cancer	0.000754	0.000768	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—thyroid cancer	0.000753	0.000767	CcSEcCtD
Carmustine—Paraesthesia—Epirubicin—thyroid cancer	0.000748	0.000762	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—thyroid cancer	0.000743	0.000757	CcSEcCtD
Carmustine—Somnolence—Epirubicin—thyroid cancer	0.000741	0.000755	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—thyroid cancer	0.000735	0.000749	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—thyroid cancer	0.000724	0.000738	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—thyroid cancer	0.000721	0.000734	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000719	0.000733	CcSEcCtD
Carmustine—Pain—Epirubicin—thyroid cancer	0.000713	0.000726	CcSEcCtD
Carmustine—Constipation—Epirubicin—thyroid cancer	0.000713	0.000726	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000703	0.000716	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—thyroid cancer	0.000697	0.00071	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—thyroid cancer	0.000692	0.000705	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—thyroid cancer	0.000687	0.0007	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—thyroid cancer	0.000687	0.000699	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—thyroid cancer	0.000685	0.000698	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000681	0.000694	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—thyroid cancer	0.00067	0.000683	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000666	0.000678	CcSEcCtD
Carmustine—Pain—Doxorubicin—thyroid cancer	0.000659	0.000672	CcSEcCtD
Carmustine—Constipation—Doxorubicin—thyroid cancer	0.000659	0.000672	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—thyroid cancer	0.000659	0.000671	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—thyroid cancer	0.000659	0.000671	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000635	0.000647	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000631	0.000642	CcSEcCtD
Carmustine—Hypersensitivity—Epirubicin—thyroid cancer	0.000614	0.000625	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—thyroid cancer	0.00061	0.000621	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—thyroid cancer	0.00061	0.000621	CcSEcCtD
Carmustine—Asthenia—Epirubicin—thyroid cancer	0.000598	0.000609	CcSEcCtD
Carmustine—Diarrhoea—Epirubicin—thyroid cancer	0.00057	0.000581	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000568	0.000579	CcSEcCtD
Carmustine—Asthenia—Doxorubicin—thyroid cancer	0.000553	0.000563	CcSEcCtD
Carmustine—Dizziness—Epirubicin—thyroid cancer	0.000551	0.000561	CcSEcCtD
Carmustine—Vomiting—Epirubicin—thyroid cancer	0.00053	0.00054	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—thyroid cancer	0.000528	0.000537	CcSEcCtD
Carmustine—Rash—Epirubicin—thyroid cancer	0.000525	0.000535	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—thyroid cancer	0.000525	0.000535	CcSEcCtD
Carmustine—Headache—Epirubicin—thyroid cancer	0.000522	0.000532	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—thyroid cancer	0.00051	0.000519	CcSEcCtD
Carmustine—Nausea—Epirubicin—thyroid cancer	0.000495	0.000504	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—thyroid cancer	0.00049	0.000499	CcSEcCtD
Carmustine—Rash—Doxorubicin—thyroid cancer	0.000486	0.000495	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—thyroid cancer	0.000486	0.000495	CcSEcCtD
Carmustine—Headache—Doxorubicin—thyroid cancer	0.000483	0.000492	CcSEcCtD
Carmustine—Nausea—Doxorubicin—thyroid cancer	0.000458	0.000467	CcSEcCtD
